VIM
ORGO icon

Villanova Investment Management’s Organogenesis Holdings ORGO Stock Holding History

Villanova Investment Management’s Portfolio ORGO Stock Details ORGO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-265,734
Closed -$760K – 59
2024
Q3 		$760K Buy
265,734
+303
+0.1% +$850 0.81% 51
2024
Q2 		$743K Buy
+265,431
New +$712K 0.79% 54

Other funds holding ORGO

SCM
Soleus Capital Management Greenwich, Connecticut $2.47B AUM 115.63% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Assenagon Asset Management
Assenagon Asset Management Senningerberg, Luxembourg $80.2B AUM 50.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Villanova Investment Management's ORGO Position: Q4 2024 in Review

Villanova Investment Management sold out of Organogenesis Holdings (ORGO) in Q4 2024, closing a stake of 265,734 shares — an estimated $760K sold.

Villanova Investment Management first reported a position in ORGO in Q2 2024 and held it in 2 quarters. The position peaked at $760K in Q3 2024. 120 funds tracked by Wall St. Rank hold ORGO as of Q4 2024.

  • Villanova Investment Management reported no remaining Organogenesis Holdings position as of Q4 2024 after selling out during the quarter.
  • Villanova Investment Management sold 265,734 Organogenesis Holdings shares in Q4 2024, an estimated $760K.
  • Villanova Investment Management first reported a position in Organogenesis Holdings in Q2 2024 and held it in 2 quarters.
  • Villanova Investment Management's Organogenesis Holdings position peaked at $760K in Q3 2024.
  • 120 funds tracked by Wall St. Rank held Organogenesis Holdings as of Q4 2024.

Based on Villanova Investment Management's 13F filing for Q4 2024, filed 12 Feb 2025.